Details of the Drug Reposition

General Information of This Drug (ID: DMNST69)

Drug Name
Metaiodobenzylguanidine I-131   DMNST69
Synonyms Azedra (TN)
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neuroendocrine cancer DISVGJET 2B72.1 Phase 2 [1]
Neuroblastoma DISVZBI4 2D11.2 Phase 2 [2]
------------------------------------------------------------------------------------
1 Application submitted Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pheochromocytoma DIS56IFV 5A75 Application submitted [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004852)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)